Chengdu Kanghua Biological Products Co., Ltd.

Chengdu Kanghua Biological Products Co., Ltd. (hereinafter referredas “Kangh”) ,established in 2004, is one of the 13 enterprises with full vaccine production capacity in Chengdu Economic and Technological Development Zone, covering an area of 30000 square meters.Kangh is equipped with the world-class biotechnology experimental center, SPF experimental animal center, high-tech GMP production workshop for bacterial and viral vaccines. Its main business includes research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine ( human diploid cell) for Human Use, freeze-dried - HDCV.